Device
deep rTMS
deep rTMS is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
unknown133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
Clinical Trials (3)
Showing 3 of 3 trials
NCT03504748Not Applicable
Deep rTMS in Parkinson Disease Pain Syndromes
NCT01932905Not Applicable
Deep rTMS in Central Neuropathic Pain Syndromes
NCT00808782Not Applicable
The Use of rTMS to Improve Theory of Mind Among Adults With Autism and Asperger's Disorder
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3